Fig. 1From: CD72, a new immune checkpoint molecule, is a novel prognostic biomarker for kidney renal clear cell carcinomaDistributions of mRNA in KIRC and identification of DEmRNA association with immunity and prognostic of KIRC patientsBack to article page